CliffBio
small molecule

MECLOFENAMATE SODIUM

MECLOFENAMATE SODIUM

Loss of exclusivity—loss of exclusivity
CompanyPar →See this company's full patent-cliff portfolio

Drug detail

Brand nameMECLOFENAMATE SODIUM
Active ingredientMECLOFENAMATE SODIUM
StrengthEQ 100MG BASE
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalMarch 1988
Marketing statusDISCN

More from Par

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

MECLOFENAMATE SODIUM patent cliff — loss of exclusivity — | CliffBio